Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study

BACKGROUND: Recently, convalescent plasma (CP) transfusion was employed for severe or critically ill patients with coronavirus disease-2019. However, the benefits of CP for patients with different conditions are still in debate. To contribute clinical evidence of CP on critically ill patients, we an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Li, Zhang, Che, Zhou, Xihui, Zhao, Zhou, Wang, Weiping, Leng, Weidong, Su, Xiao, Lian, Qizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390032/
https://www.ncbi.nlm.nih.gov/pubmed/34446049
http://dx.doi.org/10.1186/s12967-021-03028-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390032/
https://www.ncbi.nlm.nih.gov/pubmed/34446049
http://dx.doi.org/10.1186/s12967-021-03028-5

Ejemplares similares